Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Singapore: Everest Medicines to acquire Hasten Biopharmaceuticals (SG) for US$250m

Distribution Nick Herbert -
Hong Kong-listed Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialisation of innovative therapeutics, has announced that its wholly-owned subsidiary, EverSea Medicines (Singapore), has entered into a Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) to conditionally acquire the entire equity interest in its wholly-owned...

Occupational health moves from compliance to productivity tool – Investors in Healthcare talks to Eilert Hinrichs of L.E.K.

Analysis Nick Herbert -
Corporate healthcare spending is emerging as an increasingly important component of the healthcare ecosystem as employers seek to manage absenteeism and workforce productivity. Historically, occupational health services focused primarily on regulatory compliance. But Eilert Hinrichs, a partner at L.E.K. Consulting, says the sector is undergoing a strategic shift as employers increasingly view employee health as a driver of economic performance. Rising healthcare demand, combined with mounting pressure on public health systems such as the National Health Service (NHS), is pushing more responsibility toward private and employer-funded healthcare provision. Investors in Healthcare: What...